DDMAC Reasserts Its Oversight of Promotion Directed Not Only to Physicians, But Also to P&T Committees

September 11, 2007

The FDA’s Division of Drug Marketing, Advertising and Communications (“DDMAC”) issued four warning letters and two untitled letters from January through April 2007. The six letters address a wall calendar and dry erase board, a journal advertisement, a direct-to-consumer television advertisement, a retail sell sheet, a sales aid, and a physician’s presentation and hand-out to the Maryland Department of Health and Mental Hygiene’s Pharmacy and Therapeutics Committee.

Please click here to read the full article.

More Resources